Latvia
Latvia, officially known as the Republic of Latvia, is a country in the Baltic region of Northern Europe. Since its independence, Latvia has been referred to as one of the Baltic states.
Latvia is a high-income advanced economy and ranks 41st in the Human Development Index. It performs favourably in measurements of civil liberties, press freedom, internet freedom, democratic governance, living standards and peacefulness.
Healthcare budget
$1.7 billion
Inhabitants
1.9 million
GDP per capita
$22.188
Currency
Euro
World Ranking
GDP 97nd
Latvian healthcare
The Latvian healthcare system is a universal program largely funded through government taxation. It was among the lowest-ranked healthcare systems in Europe, due to excessive waiting times for treatment, insufficient access to the latest medicines, and other factors. There were 59 hospitals in Latvia in 2009, down from 94 in 2007, and 121 in 2006.
Corruption is relatively widespread in the Latvian healthcare system, although the situation has improved since the early 1990s. It has been noted that an environment conducive to corruption has been promulgated by low salaries and poorly implemented systemic reforms.
Latvian pharmaceutical environment
Latvia have signed the Joint Baltic Drug Procurement Agreement. This agreement may increase the volume of ordered medicines, thus attracting interest from more pharmaceutical companies to participate in tenders and putting manufacturers under pressure to offer discounts on pharmaceutical prices.
Some prescribed drugs, such as those used for diabetes, HIV, and TB, are subsidized by the state, and Latvian authorities have indicated that fighting tuberculosis, tick-borne encephalitis, and HIV are key priorities.
The experts in Latvia
Karin Torberger & Clas Lindbergson
Challenge us with your case and we will show you the possibilities for your product.
Services
Sales and Marketing
Entering the European market is not easy. 44 countries with different healthcare systems. What is your strategy? Apart from the Big-5, what do you do with the other 28 countries? We offer a solution for 28 countries. Sales and marketing is our core business.
Learn moreDistribution
We manage, through our logistic partners with their regional warehouses, the distribution to our region (28 countries). They have the capability to handle the most demanding of specialized product order management, storage, handling and distribution requirements.
Learn moreEarly Market Research
You know that market research is critical. It provides customer insights, competitive intelligence, behavioural tendencies, and product positioning. And market research increasingly is becoming an important component for linking R&D and marketing teams.
Learn moreMarket Access
Achieving reimbursement and getting the right price are the 2 most important drivers for a successful launch of an innovative pharmaceuticals in our part of Europe. Health Authorities in any European country decide individually based on their local regulations, policies, framework, social values and available health care budget.
Learn moreMarket Authorisation
Unlike other regions, in the EU a number of options is available to obtain a marketing authorisation. Centralised at the European Medicines Agency in Amsterdam or decentralised with the individual competent authorities of the member states, each marketing authorisation application procedure has its pros and cons. In the case of Switzerland, it has its own regulatory authority, Swissmedic, and processes.
Learn morePharmacovigilance
Pharmacovigilance is the science and activities relating to the detection, assessment, understanding and prevention of adverse effects or any other medicine-related problem.
Learn more